302 related articles for article (PubMed ID: 30257953)
1. Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.
Goss CH; Kaneko Y; Khuu L; Anderson GD; Ravishankar S; Aitken ML; Lechtzin N; Zhou G; Czyz DM; McLean K; Olakanmi O; Shuman HA; Teresi M; Wilhelm E; Caldwell E; Salipante SJ; Hornick DB; Siehnel RJ; Becker L; Britigan BE; Singh PK
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257953
[TBL] [Abstract][Full Text] [Related]
2. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
Elife; 2021 Apr; 10():. PubMed ID: 33821795
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa aggregates in cystic fibrosis sputum produce exopolysaccharides that likely impede current therapies.
Jennings LK; Dreifus JE; Reichhardt C; Storek KM; Secor PR; Wozniak DJ; Hisert KB; Parsek MR
Cell Rep; 2021 Feb; 34(8):108782. PubMed ID: 33626358
[TBL] [Abstract][Full Text] [Related]
4. Characterization of gallium resistance induced in a Pseudomonas aeruginosa cystic fibrosis isolate.
Tovar-García A; Angarita-Zapata V; Cazares A; Jasso-Chávez R; Belmont-Díaz J; Sanchez-Torres V; López-Jacome LE; Coria-Jiménez R; Maeda T; García-Contreras R
Arch Microbiol; 2020 Apr; 202(3):617-622. PubMed ID: 31773196
[TBL] [Abstract][Full Text] [Related]
5. Gallium-Protoporphyrin IX Inhibits
Hijazi S; Visca P; Frangipani E
Front Cell Infect Microbiol; 2017; 7():12. PubMed ID: 28184354
[No Abstract] [Full Text] [Related]
6. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
[TBL] [Abstract][Full Text] [Related]
8. Levofloxacin inhalation solution for the treatment of chronic Pseudomonas aeruginosa infection among patients with cystic fibrosis.
Stockmann C; Hillyard B; Ampofo K; Spigarelli MG; Sherwin CM
Expert Rev Respir Med; 2015 Feb; 9(1):13-22. PubMed ID: 25417708
[TBL] [Abstract][Full Text] [Related]
9. Desulfurization of mucin by Pseudomonas aeruginosa: influence of sulfate in the lungs of cystic fibrosis patients.
Robinson CV; Elkins MR; Bialkowski KM; Thornton DJ; Kertesz MA
J Med Microbiol; 2012 Dec; 61(Pt 12):1644-1653. PubMed ID: 22918866
[TBL] [Abstract][Full Text] [Related]
10. Calprotectin-Mediated Zinc Chelation Inhibits Pseudomonas aeruginosa Protease Activity in Cystic Fibrosis Sputum.
Vermilyea DM; Crocker AW; Gifford AH; Hogan DA
J Bacteriol; 2021 Jun; 203(13):e0010021. PubMed ID: 33927050
[TBL] [Abstract][Full Text] [Related]
11. Safety and pharmacokinetics of ciprofloxacin dry powder for inhalation in cystic fibrosis: a phase I, randomized, single-dose, dose-escalation study.
Stass H; Delesen H; Nagelschmitz J; Staab D
J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):106-15. PubMed ID: 25050456
[TBL] [Abstract][Full Text] [Related]
12. Anti-PcrV antibody in cystic fibrosis: a novel approach targeting Pseudomonas aeruginosa airway infection.
Milla CE; Chmiel JF; Accurso FJ; VanDevanter DR; Konstan MW; Yarranton G; Geller DE;
Pediatr Pulmonol; 2014 Jul; 49(7):650-8. PubMed ID: 24019259
[TBL] [Abstract][Full Text] [Related]
13. The Small RNA ErsA Plays a Role in the Regulatory Network of Pseudomonas aeruginosa Pathogenicity in Airway Infections.
Ferrara S; Rossi A; Ranucci S; De Fino I; Bragonzi A; Cigana C; Bertoni G
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055260
[TBL] [Abstract][Full Text] [Related]
14. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
Pritchard MF; Powell LC; Jack AA; Powell K; Beck K; Florance H; Forton J; Rye PD; Dessen A; Hill KE; Thomas DW
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630204
[TBL] [Abstract][Full Text] [Related]
15. The problems of antibiotic resistance in cystic fibrosis and solutions.
López-Causapé C; Rojo-Molinero E; Macià MD; Oliver A
Expert Rev Respir Med; 2015 Feb; 9(1):73-88. PubMed ID: 25541089
[TBL] [Abstract][Full Text] [Related]
16. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of biofilm testing to select antibiotics for cystic fibrosis airway infection.
Moskowitz SM; Emerson JC; McNamara S; Shell RD; Orenstein DM; Rosenbluth D; Katz MF; Ahrens R; Hornick D; Joseph PM; Gibson RL; Aitken ML; Benton WW; Burns JL
Pediatr Pulmonol; 2011 Feb; 46(2):184-92. PubMed ID: 20963843
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
19. Agmatine accumulation by Pseudomonas aeruginosa clinical isolates confers antibiotic tolerance and dampens host inflammation.
McCurtain JL; Gilbertsen AJ; Evert C; Williams BJ; Hunter RC
J Med Microbiol; 2019 Mar; 68(3):446-455. PubMed ID: 30688634
[TBL] [Abstract][Full Text] [Related]
20. Eradication of Pseudomonas aeruginosa in cystic fibrosis.
Eber E; Thalhammer GH; Zach MS
Eur Respir J; 2006 Feb; 27(2):438-9. PubMed ID: 16452606
[No Abstract] [Full Text] [Related]
[Next] [New Search]
